Premium
Current treatment preferences in chronic myeloid leukemia: The Mayo Clinic Physicians' survey
Author(s) -
Begna Kebede,
AlKali Aref,
Elliott Michelle,
Foran James,
Gangat Naseema,
Hogan William,
Hook Christopher,
Leis Jose,
Litzow Mark,
Mesa Ruben,
Palmer Jeanne,
Pardanani Animesh,
Patnaik Mrinal,
Rivera Candido,
Sproat Lisa,
Tibes Raoul,
WolanskyjSpinner Alexandra,
Tefferi Ayalew
Publication year - 2017
Publication title -
american journal of hematology
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 2.456
H-Index - 105
eISSN - 1096-8652
pISSN - 0361-8609
DOI - 10.1002/ajh.24866
Subject(s) - nilotinib , medicine , dasatinib , imatinib , myeloid leukemia , chronic myelogenous leukemia , imatinib mesylate , oncology , tyrosine kinase inhibitor , cancer , leukemia